Marc-Andre Lebel
Amministratore Delegato presso FRX INNOVATIONS INC.
Relazioni attive
| Nome | Sesso | Età | Società collegate | Collaborazione |
|---|---|---|---|---|
| Radu Pislariu | M | - |
Laurent Pharmaceuticals, Inc.
 Laurent Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Laurent Pharmaceuticals, Inc. operates as a biopharmaceutical company. The firm develops clinical stage, orally-active drug candidate with potential to modulate the immuno-inflammatory response in cystic fibrosis patients. The company was founded in 2012 and is headquartered in Montr?al, Canada. | - |
| Ross Haghighat | M | 60 |
FRX Polymers, Inc.
 FRX Polymers, Inc. Chemicals: SpecialtyProcess Industries FRX Polymers, Inc. manufactures flame retardant plastics and additives. Its products include homopolymers, copolymers and oligomers additive and oligomers reactive. The firm serves fibers, electrical equipment and consumer electronics, transportation, building and construction markets. The company was founded by Marc A. Lebel and Ross Haghighat in 2007 and is headquartered in Chelmsford, MA. | 17 anni |
| Christopher P. Joyce | M | - |
FRX Polymers, Inc.
FRX Polymers, Inc. Chemicals: SpecialtyProcess Industries FRX Polymers, Inc. manufactures flame retardant plastics and additives. Its products include homopolymers, copolymers and oligomers additive and oligomers reactive. The firm serves fibers, electrical equipment and consumer electronics, transportation, building and construction markets. The company was founded by Marc A. Lebel and Ross Haghighat in 2007 and is headquartered in Chelmsford, MA. | - |
| Bernhard Mohr | M | - |
FRX Polymers, Inc.
FRX Polymers, Inc. Chemicals: SpecialtyProcess Industries FRX Polymers, Inc. manufactures flame retardant plastics and additives. Its products include homopolymers, copolymers and oligomers additive and oligomers reactive. The firm serves fibers, electrical equipment and consumer electronics, transportation, building and construction markets. The company was founded by Marc A. Lebel and Ross Haghighat in 2007 and is headquartered in Chelmsford, MA. | - |
| Johane Boucher-Champagne | F | 70 |
Anapharm, Inc.
 Anapharm, Inc. Miscellaneous Commercial ServicesCommercial Services Anapharm, Inc. is a hospital and health care company. It provides clinical trials and bioanalytical research services. The company is headquartered in Québec, Canada.
inVentiv Health Clinical, Inc.
 inVentiv Health Clinical, Inc. Miscellaneous Commercial ServicesCommercial Services inVentiv Health Clinical, Inc. provides clinical research and drug development services. It provides its services to the pharmaceutical, biotechnology, generic drug, and medical device industries. The firm offers clinical-development solutions including consulting services, Phase I clinical studies, bioequivalency and pharmacodynamic studies, bioanalytical analyses, and Phase II, III, and IV clinical development programs. The company was founded in 1984 and is headquartered in Princeton, NJ. | 26 anni |
| Mark Lotz | M | 59 | - | |
| James Cassina | M | 67 | - | |
| Fanglu Wang | M | - | - | |
| Ekaterina Terskin | M | - | - | |
| Malken Bayrakdarian | M | - |
NuChem Sciences, Inc.
 NuChem Sciences, Inc. BiotechnologyHealth Technology Part of Sygnature Discovery Ltd., NuChem Sciences, Inc. was founded in 2011 and is a leading contract research organization in drug discovery and chemical development. The company is based in Saint-Laurent, Canada. NuChem Sciences, which employs 300 scientific and support staff, offers a range of standalone and integrated discovery services in chemistry, biochemistry, in-vitro biology, DMPK, structural biology, and in vivo pharmacology. NuChem Sciences' expert chemistry services for drug discovery feature synthetic, medicinal, and analytical solutions. The Canadian company also offers advanced ADME studies, metabolic stability analysis, and tailored solutions for drug discovery. NuChem Sciences was acquired by Sygnature Discovery Ltd. on July 31, 2023. | - |
| Fang Lu Wang | M | 60 |
FRX Polymers, Inc.
FRX Polymers, Inc. Chemicals: SpecialtyProcess Industries FRX Polymers, Inc. manufactures flame retardant plastics and additives. Its products include homopolymers, copolymers and oligomers additive and oligomers reactive. The firm serves fibers, electrical equipment and consumer electronics, transportation, building and construction markets. The company was founded by Marc A. Lebel and Ross Haghighat in 2007 and is headquartered in Chelmsford, MA. | - |
| Sergio Iorio | M | 64 |
FRX Polymers, Inc.
FRX Polymers, Inc. Chemicals: SpecialtyProcess Industries FRX Polymers, Inc. manufactures flame retardant plastics and additives. Its products include homopolymers, copolymers and oligomers additive and oligomers reactive. The firm serves fibers, electrical equipment and consumer electronics, transportation, building and construction markets. The company was founded by Marc A. Lebel and Ross Haghighat in 2007 and is headquartered in Chelmsford, MA. | - |
| Patrick Muezers | M | - | 1 anni | |
| Graham Farrell | M | - | - | |
| François Mongrain | M | - |
Laurent Pharmaceuticals, Inc.
Laurent Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Laurent Pharmaceuticals, Inc. operates as a biopharmaceutical company. The firm develops clinical stage, orally-active drug candidate with potential to modulate the immuno-inflammatory response in cystic fibrosis patients. The company was founded in 2012 and is headquartered in Montr?al, Canada. | - |
| Yves Rosconi | M | - |
Laurent Pharmaceuticals, Inc.
Laurent Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Laurent Pharmaceuticals, Inc. operates as a biopharmaceutical company. The firm develops clinical stage, orally-active drug candidate with potential to modulate the immuno-inflammatory response in cystic fibrosis patients. The company was founded in 2012 and is headquartered in Montr?al, Canada. | - |
| Kevin A. Giese | M | - |
Laurent Pharmaceuticals, Inc.
Laurent Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Laurent Pharmaceuticals, Inc. operates as a biopharmaceutical company. The firm develops clinical stage, orally-active drug candidate with potential to modulate the immuno-inflammatory response in cystic fibrosis patients. The company was founded in 2012 and is headquartered in Montr?al, Canada. | - |
| Mike Goode | M | - | - |
Grafico relazionale
Relazione in diverse aziende
Relazioni precedenti
| Nome | Sesso | Età | Società collegate | Collaborazione |
|---|---|---|---|---|
| Arnold Hantman | M | 88 |
inVentiv Health Clinical, Inc.
inVentiv Health Clinical, Inc. Miscellaneous Commercial ServicesCommercial Services inVentiv Health Clinical, Inc. provides clinical research and drug development services. It provides its services to the pharmaceutical, biotechnology, generic drug, and medical device industries. The firm offers clinical-development solutions including consulting services, Phase I clinical studies, bioequivalency and pharmacodynamic studies, bioanalytical analyses, and Phase II, III, and IV clinical development programs. The company was founded in 1984 and is headquartered in Princeton, NJ. | 21 anni |
| Jeffrey P. McMullen | M | 72 |
inVentiv Health Clinical, Inc.
inVentiv Health Clinical, Inc. Miscellaneous Commercial ServicesCommercial Services inVentiv Health Clinical, Inc. provides clinical research and drug development services. It provides its services to the pharmaceutical, biotechnology, generic drug, and medical device industries. The firm offers clinical-development solutions including consulting services, Phase I clinical studies, bioequivalency and pharmacodynamic studies, bioanalytical analyses, and Phase II, III, and IV clinical development programs. The company was founded in 1984 and is headquartered in Princeton, NJ. | 13 anni |
| Sean N. Karamchandani | M | - | - | |
| Michael Singer | M | 59 | 3 anni | |
| Patrice Hugo | M | 62 | 2 anni | |
| Jan-Pleun Lens | M | - |
FRX Polymers, Inc.
FRX Polymers, Inc. Chemicals: SpecialtyProcess Industries FRX Polymers, Inc. manufactures flame retardant plastics and additives. Its products include homopolymers, copolymers and oligomers additive and oligomers reactive. The firm serves fibers, electrical equipment and consumer electronics, transportation, building and construction markets. The company was founded by Marc A. Lebel and Ross Haghighat in 2007 and is headquartered in Chelmsford, MA. | 9 anni |
| Jack Levine | M | 73 |
PharmaNet, Inc.
 PharmaNet, Inc. Medical DistributorsDistribution Services PharmaNet, Inc. researches and develops new drugs and provides clinical development & consulting services. Its services include strategic planning, data management, bio-statistics, site management, study monitoring, protocol/CRF design, project management, information technology, quality control and assurance and regulatory affairs. The company was founded in 1996 by Jeffrey P. McMullen and is headquartered in Princeton, NJ. | 8 anni |
| Louis P. Lacasse | M | 67 | 15 anni | |
| Michel Lassonde | M | 82 | 3 anni | |
| Joseph Walewicz | M | 55 | 3 anni | |
| Mattie Chinks | M | 74 | 4 anni | |
| Peter G. Tombros | M | 81 |
inVentiv Health Clinical, Inc.
inVentiv Health Clinical, Inc. Miscellaneous Commercial ServicesCommercial Services inVentiv Health Clinical, Inc. provides clinical research and drug development services. It provides its services to the pharmaceutical, biotechnology, generic drug, and medical device industries. The firm offers clinical-development solutions including consulting services, Phase I clinical studies, bioequivalency and pharmacodynamic studies, bioanalytical analyses, and Phase II, III, and IV clinical development programs. The company was founded in 1984 and is headquartered in Princeton, NJ. | - |
| François Jetté | M | - | 7 anni | |
| Johan Keppens | M | - |
FRX Polymers, Inc.
FRX Polymers, Inc. Chemicals: SpecialtyProcess Industries FRX Polymers, Inc. manufactures flame retardant plastics and additives. Its products include homopolymers, copolymers and oligomers additive and oligomers reactive. The firm serves fibers, electrical equipment and consumer electronics, transportation, building and construction markets. The company was founded by Marc A. Lebel and Ross Haghighat in 2007 and is headquartered in Chelmsford, MA. | 3 anni |
| Mark J. Busgang | M | 68 | 13 anni | |
| Mark di Ianni | M | 73 |
inVentiv Health Clinical, Inc.
inVentiv Health Clinical, Inc. Miscellaneous Commercial ServicesCommercial Services inVentiv Health Clinical, Inc. provides clinical research and drug development services. It provides its services to the pharmaceutical, biotechnology, generic drug, and medical device industries. The firm offers clinical-development solutions including consulting services, Phase I clinical studies, bioequivalency and pharmacodynamic studies, bioanalytical analyses, and Phase II, III, and IV clinical development programs. The company was founded in 1984 and is headquartered in Princeton, NJ. | - |
| Thomas Joseph Newman | M | 75 |
inVentiv Health Clinical, Inc.
inVentiv Health Clinical, Inc. Miscellaneous Commercial ServicesCommercial Services inVentiv Health Clinical, Inc. provides clinical research and drug development services. It provides its services to the pharmaceutical, biotechnology, generic drug, and medical device industries. The firm offers clinical-development solutions including consulting services, Phase I clinical studies, bioequivalency and pharmacodynamic studies, bioanalytical analyses, and Phase II, III, and IV clinical development programs. The company was founded in 1984 and is headquartered in Princeton, NJ. | - |
| Arnold Golieb | M | 89 |
inVentiv Health Clinical, Inc.
inVentiv Health Clinical, Inc. Miscellaneous Commercial ServicesCommercial Services inVentiv Health Clinical, Inc. provides clinical research and drug development services. It provides its services to the pharmaceutical, biotechnology, generic drug, and medical device industries. The firm offers clinical-development solutions including consulting services, Phase I clinical studies, bioequivalency and pharmacodynamic studies, bioanalytical analyses, and Phase II, III, and IV clinical development programs. The company was founded in 1984 and is headquartered in Princeton, NJ. | 7 anni |
| Rolf Classon | M | 79 |
inVentiv Health Clinical, Inc.
inVentiv Health Clinical, Inc. Miscellaneous Commercial ServicesCommercial Services inVentiv Health Clinical, Inc. provides clinical research and drug development services. It provides its services to the pharmaceutical, biotechnology, generic drug, and medical device industries. The firm offers clinical-development solutions including consulting services, Phase I clinical studies, bioequivalency and pharmacodynamic studies, bioanalytical analyses, and Phase II, III, and IV clinical development programs. The company was founded in 1984 and is headquartered in Princeton, NJ. | 3 anni |
| Per Wold-Olsen | M | 76 |
inVentiv Health Clinical, Inc.
inVentiv Health Clinical, Inc. Miscellaneous Commercial ServicesCommercial Services inVentiv Health Clinical, Inc. provides clinical research and drug development services. It provides its services to the pharmaceutical, biotechnology, generic drug, and medical device industries. The firm offers clinical-development solutions including consulting services, Phase I clinical studies, bioequivalency and pharmacodynamic studies, bioanalytical analyses, and Phase II, III, and IV clinical development programs. The company was founded in 1984 and is headquartered in Princeton, NJ. | 3 anni |
| David M. Olivier | M | 80 |
inVentiv Health Clinical, Inc.
inVentiv Health Clinical, Inc. Miscellaneous Commercial ServicesCommercial Services inVentiv Health Clinical, Inc. provides clinical research and drug development services. It provides its services to the pharmaceutical, biotechnology, generic drug, and medical device industries. The firm offers clinical-development solutions including consulting services, Phase I clinical studies, bioequivalency and pharmacodynamic studies, bioanalytical analyses, and Phase II, III, and IV clinical development programs. The company was founded in 1984 and is headquartered in Princeton, NJ. | 6 anni |
| Jesus Jon Rojas | M | 57 |
inVentiv Health Clinical, Inc.
inVentiv Health Clinical, Inc. Miscellaneous Commercial ServicesCommercial Services inVentiv Health Clinical, Inc. provides clinical research and drug development services. It provides its services to the pharmaceutical, biotechnology, generic drug, and medical device industries. The firm offers clinical-development solutions including consulting services, Phase I clinical studies, bioequivalency and pharmacodynamic studies, bioanalytical analyses, and Phase II, III, and IV clinical development programs. The company was founded in 1984 and is headquartered in Princeton, NJ. | 7 anni |
| Lewis R. l. Elias | M | 98 |
inVentiv Health Clinical, Inc.
inVentiv Health Clinical, Inc. Miscellaneous Commercial ServicesCommercial Services inVentiv Health Clinical, Inc. provides clinical research and drug development services. It provides its services to the pharmaceutical, biotechnology, generic drug, and medical device industries. The firm offers clinical-development solutions including consulting services, Phase I clinical studies, bioequivalency and pharmacodynamic studies, bioanalytical analyses, and Phase II, III, and IV clinical development programs. The company was founded in 1984 and is headquartered in Princeton, NJ. | 7 anni |
| Leonard I. Weinstein | M | 79 |
inVentiv Health Clinical, Inc.
inVentiv Health Clinical, Inc. Miscellaneous Commercial ServicesCommercial Services inVentiv Health Clinical, Inc. provides clinical research and drug development services. It provides its services to the pharmaceutical, biotechnology, generic drug, and medical device industries. The firm offers clinical-development solutions including consulting services, Phase I clinical studies, bioequivalency and pharmacodynamic studies, bioanalytical analyses, and Phase II, III, and IV clinical development programs. The company was founded in 1984 and is headquartered in Princeton, NJ. | 6 anni |
| Kevin Trudel | M | - |
FRX Polymers, Inc.
FRX Polymers, Inc. Chemicals: SpecialtyProcess Industries FRX Polymers, Inc. manufactures flame retardant plastics and additives. Its products include homopolymers, copolymers and oligomers additive and oligomers reactive. The firm serves fibers, electrical equipment and consumer electronics, transportation, building and construction markets. The company was founded by Marc A. Lebel and Ross Haghighat in 2007 and is headquartered in Chelmsford, MA. | 6 anni |
Statistiche
| Paese | Relazioni | % del totale |
|---|---|---|
| Stati Uniti | 29 | 67.44% |
| Canada | 15 | 34.88% |
Età delle relazioni
Attive
Scorse
Uomo
Donna
Amministratori
Dirigenti
Provenienza delle relazioni
- Borsa valori
- Insiders
- Marc-Andre Lebel
- Contatti personali
